Carcinoid syndrome staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 22: | Line 22: | ||
*T4-Tumor invades visceral peritoneum (serosal) or other organs or adjacent structures | *T4-Tumor invades visceral peritoneum (serosal) or other organs or adjacent structures | ||
::For any T, add (m) for multiple tumors | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 14:22, 21 September 2015
Carcinoid syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Carcinoid syndrome staging On the Web |
American Roentgen Ray Society Images of Carcinoid syndrome staging |
Risk calculators and risk factors for Carcinoid syndrome staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Staging
Definitions of TNM
Neuroendocrine Tumors: Stomach
- Primary Tumor (T)
- TX-Primary tumor cannot be assessed
- T0-No evidence of primary tumor
- Tis-Carcinoma in situ/dysplasia (tumor size <0.5 mm), confined to mucosa
- T1-Tumor invades lamina propria or submucosa and ≤1 cm in size
- T2-Tumor invades muscularis propria or >1 cm in size
- T3-Tumor penetrates subserosa
- T4-Tumor invades visceral peritoneum (serosal) or other organs or adjacent structures
- For any T, add (m) for multiple tumors